GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age
London, UK 21 May 2018 --GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 24, 2018 Category: Drugs & Pharmacology Source Type: news

AcelRx Announces FDA Acceptance of NDA for DSUVIA
REDWOOD CITY, Calif., May 24, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, today announced the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 24, 2018 Category: Drugs & Pharmacology Source Type: news

Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
MUMBAI& PRINCETON, N.J.& KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC. (Churchill) today announced that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

Finasteride Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

Belladonna and Opium Suppository (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos La FDA evaluar á el riesgo potencial de defectos cong é nitos del tubo neural ocasionados por el medicamento contra el HIV dolutegravir (Juluca, Tivicay, Triumeq)
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos La FDA evaluar á el riesgo potencial de defectos congénitos del tubo neural ocasionados por el medicamento contra el HIV dolutegravir (Juluca, Tivicay, Triumeq)
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

Teva Confirms September PDUFA Date for Fremanezumab
JERUSALEM--(BUSINESS WIRE)--May 23, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today confirmed that the U.S. Food and Drug Administration (FDA) has extended the goal date of the Biologics License Application (BLA) for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir (Viekira XR) Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Magnesium Sulfate Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Lanoxin (digoxin) Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Hydrochlorothiazide and Lisinopril Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Ombitasvir; Paritaprevir; Ritonavir (Technivie) Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Risk of serious and potentially fatal blood disorder prompts FDA action on oral over-the-counter benzocaine products used for teething and mouth pain and prescription local anesthetics
FDA is taking safety actions regarding over-the-counter benzocaine oral drug products and prescription local anesthetics. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Lilly's Taltz (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area
INDIANAPOLIS, May 22, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label update for Taltz (ixekizumab) injection 80 mg/mL to include data in psoriasis... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray
PHOENIX, May 22, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, confirmed today that an expert panel convened by... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

FDA to Review Zynquista (sotagliflozin) as Potential Treatment for Type 1 Diabetes
BRIDGEWATER, N.J. and THE WOODLANDS, Texas, May 22, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin). The investigational oral treatment would be used in addition... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

Vancomycin for Primary Sclerosing Cholangitis Vancomycin for Primary Sclerosing Cholangitis
This review summarizes the current evidence on the use of vancomycin in the treatment of primary sclerosing cholangitis and explores future research areas of interest.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 22, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure
May 21, 2018 -- The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Doptelet (avatrombopag) for Thrombocytopenia Patients with Chronic Liver Disease who are Undergoing a Medical Procedure
May 21, 2018 -- The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

Enforcement Policy -- OTC Sunscreen Drug Products Marketed Without an Approved Application
Compliance (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females: Erratum -
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

National Pharmacy Board Elections 2018
English Pharmacy Board Election The following candidates (listed in alphabetical order)have been elected to the four substantive vacancies on the English Pharmacy Board: Claire Anderson Sultan Dajan (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

Valproate use by women and girls - updated MHRA guidance
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued updated Guidance for Valproate use by women and girls which includes an updated toolkit. Valproate must no longer be used in a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

erenumab (Aimovig)
Title: erenumab (Aimovig)Category: MedicationsCreated: 5/21/2018 12:00:00 AMLast Editorial Review: 5/21/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Prolia (denosumab) for Glucocorticoid-Induced Osteoporosis
THOUSAND OAKS, Calif., May 21, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of Prolia (denosumab) for the treatment of glucocorticoid-induced osteoporosis (GIOP) in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

Glenmark Pharmaceuticals Announces the Company's First NDA for Ryaltris for Patients with Seasonal Allergic Rhinitis
MAHWAH, N.J., May 21, 2018 /PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food& Drug Administration (FDA) for its leading... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)
The U.S. Food and Drug Administration (FDA) is alerting the public that serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies born to women treated with dolutegravir (Juluca, Tivicay, Triumeq) used to treat human immunodeficiency virus (HIV). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 18, 2018 Category: Drugs & Pharmacology Source Type: news

Kevzara (Sarilumab Injection, For Subcutaneous Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 18, 2018 Category: Drugs & Pharmacology Source Type: news

The Opioid Crisis: Prevention, Pain Management and Pharmacology, Social Impact and Best Practices for Program Development and Effectiveness Webinar
June 5, 2018 10:00-11:30am ET. (Source: HSR Information Central)
Source: HSR Information Central - May 18, 2018 Category: International Medicine & Public Health Source Type: news

Abuse-Deterrent Opioid Formulations Abuse-Deterrent Opioid Formulations
How do abuse-deterrent opioid formulations work--and are they effective? This review details the mechanisms and pharmacology of 10 abuse-deterrent formulations currently approved in the US.Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2018 Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news

Agile Therapeutics, Inc. Provides Regulatory Update on Twirla (AG200-15) for the Prevention of Pregnancy
PRINCETON, N.J., May 18, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company, today announced the content of the official minutes from its Type A meeting with the U.S. Food and Drug Administration (FDA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 18, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine
May 17, 2018 -- The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 18, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Lokelma (sodium zirconium cyclosilicate) for the Treatment of Adults with Hyperkalemia
May 18, 2018 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Lokelma (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of hyperkalemia in adults. Hyperkalemia is a serious condition... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 18, 2018 Category: Drugs & Pharmacology Source Type: news

Medical advice alert: Home use and Point of Care blood glucose monitoring system
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert for Home use and Point of Care blood glucose monitoring system... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 18, 2018 Category: Drugs & Pharmacology Source Type: news

RPS in Scotland looking for member representative on the SIGN Council
An exciting opportunity has arisen for a member of the Royal Pharmaceutical Society (RPS) in Scotland to represent us on the Scottish Intercollegiate Guidelines Network (SIGN) Council. Members of S (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

RPS in Scotland wants to hear your experience of workforce pressures
The RPS in Scotland has been invited to give evidence to Scottish Labour’s Workforce Commission in the summer. As always, the Society is keen on ensuring that its evidence is fully informed by t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

Gail Fleming joins the RPS as new Director of Education
The Royal Pharmaceutical Society is pleased to announce the appointment of Gail Fleming FRPharmS as its new Director of Education. Education is a key part of the Society’s strategy. As such, Ga (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

Company led recall - Unlicensed Medicine Phenytoin 90mg/5ml Oral Suspension
The Medicines and Healthcare Products Regulatory Agency (MHRA) have issued a company led recall for specific batches of unlicensed medicine Phenytoin 90mg/5ml Oral Suspension (Rosemont Pharmaceuticals (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

Andexxa (Coagulation Factor Xa (recombinant), Inactivated-zhzo for Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

Plenvu (Polyethylene Glycol 3350 with Electrolytes for Oral Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

Fasenra (Benralizumab for Subcutaneous Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

RPS Wales welcomes Assembly Committee findings on anti-psychotics
The Royal Pharmaceutical Society in Wales has welcomed recommendations of the National Assembly for Wales's Health, Social Care and Sport Committee report into the inappropriate use of antipsychot (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Lucemyra (lofexidine hydrochloride) as the First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms
May 16, 2018 -- The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 16, 2018 Category: Drugs & Pharmacology Source Type: news

New care home webinars from NHS England and RPS
NHS England and the Royal Pharmaceutical Societyare hosting four separate webinars on 12, 19, 26 and 27June to help pharmacists, pharmacy technicians, providers, STPs/ICSsand commissioners find out mo (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 16, 2018 Category: Drugs & Pharmacology Source Type: news

RPS invites your views on education and training standards for pharmacist independent prescribers
We will be responding to the General Pharmaceutical Council’s (GPhC) consultation on education and training standards for pharmacist independent prescribers, and are inviting members’ view (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 16, 2018 Category: Drugs & Pharmacology Source Type: news

Medicines safety: indicators for safer prescribing (England)
The Medicines Safety Programme has developed a series of indicators to inform safer prescribing practice, helping pharmacists, clinicians and patients to review prescribed medicines and prevent avoida (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia
May 15, 2018 -- The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 15, 2018 Category: Drugs & Pharmacology Source Type: news

Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 15, 2018 Category: Drugs & Pharmacology Source Type: news